These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 33833937)

  • 21. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
    Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
    J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immune-related risk gene signature predicts the prognosis of breast cancer.
    Cao W; Jiang Y; Ji X; Ma L
    Breast Cancer; 2021 May; 28(3):653-663. PubMed ID: 33400208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer.
    Miao TW; Yang DQ; Gao LJ; Yin J; Zhu Q; Liu J; He YQ; Chen X
    Front Mol Biosci; 2022; 9():942402. PubMed ID: 36052170
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer.
    Zhao H; Zhang S; Shao S; Fang H
    Front Endocrinol (Lausanne); 2020; 11():510. PubMed ID: 32849296
    [No Abstract]   [Full Text] [Related]  

  • 29. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
    Zhang Y; Tang Y; Guo C; Li G
    Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
    Wu Y; Wang J; Ge L; Hu Q
    Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
    Liu B; Fu T; He P; Du C; Xu K
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

  • 35. Apoptosis-Associated Gene Expression Profiling Is One New Prognosis Risk Predictor of Human Rectal Cancer.
    Zhu Q; Wu X; Ma L; Xue H
    Dis Markers; 2022; 2022():4596810. PubMed ID: 35502302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.